A Gallamini
Overview
Explore the profile of A Gallamini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
66
Citations
560
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Gallamini A, Meignan M
Eur J Nucl Med Mol Imaging
. 2017 Oct;
45(1):1-3.
PMID: 29026947
No abstract available.
3.
Zaucha J, Malkowski B, Chauvie S, Subocz E, Tajer J, Kulikowski W, et al.
Ann Oncol
. 2017 Sep;
28(12):3051-3057.
PMID: 28950332
Background: Interim PET after two ABVD cycles (iPET2) predicts treatment outcome in classical Hodgkin's lymphoma. To test whether an earlier assessment of chemosensitivity would improve the prediction accuracy, we launched...
4.
Gallamini A, Kostakoglu L
Ann Oncol
. 2015 May;
26(6):1045-1047.
PMID: 26003616
No abstract available.
5.
Mauro F, Chauvie S, Paoloni F, Biggi A, Cimino G, Rago A, et al.
Leukemia
. 2015 Feb;
29(6):1360-5.
PMID: 25650091
In order to evaluate the predictive value of positron emission tomography-computed tomography (PET/CT) in discriminating the presence of a Richter's syndrome (RS) or a second malignancy (SM), as well as...
6.
Corradini P, Marchetti M, Barosi G, Billio A, Gallamini A, Pileri S, et al.
Ann Oncol
. 2014 Apr;
25(12):2339-2350.
PMID: 24723488
Background: In order to promote widespread adoption of appropriate clinical practice, the Italian Society of Hematology (SIE), and the affiliate societies SIES (Italian Society of Experimental Hematology) and GITMO (Italian...
7.
Corradini P, Vitolo U, Rambaldi A, Miceli R, Patriarca F, Gallamini A, et al.
Leukemia
. 2014 Mar;
28(9):1885-91.
PMID: 24662801
Peripheral T-cell lymphomas (PTCLs) receiving conventional treatment have a poor clinical outcome. We conducted a phase II study to evaluate the feasibility and efficacy of chemo-immunotherapy in young (⩽60 years...
8.
Luminari S, Biasoli I, Versari A, Rattotti S, Bottelli C, Rusconi C, et al.
Ann Oncol
. 2014 Jan;
25(2):442-7.
PMID: 24412823
Background: [18F]fluorodeoxyglucose-positron emission tomography (PET) is emerging as a strong diagnostic and prognostic tool in follicular lymphoma (FL) patients. Patients And Methods: In a subset analysis of the FOLL05 trial...
9.
Gallamini A, Di Raimondo F, La Nasa G, Romano A, Borra A, Greco M
Immunol Lett
. 2013 Oct;
155(1-2):56-9.
PMID: 24140162
The prognostic models in Hodgkin lymphoma (HL) such as the International Prognostic Score (IPS), retrospectively constructed in the last twenty years from different cohorts of patients treated with ABVD or...
10.
Luminari S, Biasoli I, Arcaini L, Versari A, Rusconi C, Merli F, et al.
Ann Oncol
. 2013 Apr;
24(8):2108-12.
PMID: 23585513
Background: The role of [¹⁸F] fluorodeoxyglucose (FDG)-positron emission tomography (PET) in follicular lymphoma (FL) staging is not yet determined. Patients And Methods: The aim of the present study was to...